MENU
FLNA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Filana Therapeutics (FLNA) Earnings Date & Reports
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A... Show more
Industry: #Pharmaceuticals Other
A.I. Advisor
published Earnings
FLNA is expected to report earnings to -20 cents per share on August 05
Q2'26
Est.
$-0.21
Q1'26
Beat
by $0.10
Q4'25
Beat
by $0.01
The last earnings report on May 07 showed earnings per share of -20 cents, beating the estimate of -31 cents. With 241.89K shares outstanding, the current market capitalization sits at 59.66M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of novel drugs
Industry Biotechnology
Profile
Details
Industry
Pharmaceuticals Other
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A